<div id="readability-page-1"><div><p>Health-care companies rose amid deal activity.</p><p>    Biopharmaceutical company AbbVie is in advanced talks to buy cancer-drug biotech Revolution Medicines. </p><p>    Shares of obesity-drug maker Eli Lilly rose, testing all-time highs. </p><p>    Trump administration officials made sweeping changes to U.S. federal dietary guidelines, recommending that people avoid highly processed foods, dramatically increase protein intake and skip added sugar. </p><p>   Write to Rob Curran at rob.curran@dowjones.com </p><p>    (END) Dow Jones Newswires</p><p>01-07-26 1846ET</p></div></div>

艾伯維

禮來

<p>醫療保健公司在交易活動中上漲。生物製藥公司艾伯維正在與癌症藥物生物技術公司 Revolution Medicines 進行高級談判。肥胖藥物製造商禮來的股票上漲，測試歷史最高點。特朗普政府官員對美國聯邦飲食指南進行了大幅修改，建議人們避免高度加工的食品，顯著增加蛋白質攝入量，並跳過添加糖。請聯繫 Rob Curran，郵箱為 rob.curran@dowjones.com (完) 道瓊斯新聞社 01-07-26 1846ET</p>

由於交易活動，醫療保健板塊上漲——醫療保健綜述